共 50 条
- [12] Use of Surrogate Versus Clinical Markers in Trials for HIV Infection Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 347 - 352
- [13] Use of surrogate versus clinical markers in trials for HIV infection DRUG INFORMATION JOURNAL, 1999, 33 (02): : 347 - 352
- [15] Virologic and regimen termination surrogate end points in AIDS clinical trials JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (06): : 777 - 784
- [17] LABORATORY MARKERS AS POTENTIAL SURROGATES FOR CLINICAL OUTCOMES IN AIDS TRIALS JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 : S69 - S71
- [18] Biomarkers as surrogate endpoints in clinical trials for HIV/AIDS: a model for other diseases? BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 13 - 17
- [19] Surrogate markers in AIDS research - Is there truth in numbers? JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02): : 161 - 162